| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |